John A. Butler, MD

Patrick K. Lee, MD is a board-certified dermatologist specializing in Mohs micrographic surgery, dermatologic surgery, aesthetic dermatology, cutaneous laser therapy, and skin cancer reconstruction. With extensive experience and expertise, Dr. Lee offers comprehensive care for all skin conditions and disorders. He is a professor and Vice Chair of the Department of Dermatology at UCI School of Medicine, as well as the Director of Dermatologic Surgery. Dr. Lee is a Fellow of the American Academy of Dermatology, American College of Mohs Surgery, and American Society for Dermatologic Surgery, and has received numerous awards and recognition for his excellence in the field. Dr. Lee completed his medical education at the Keck School of Medicine at USC, followed by an internship in internal medicine at Harbor-UCLA Medical Center. He then pursued a residency in dermatology at UCLA School of Medicine and a fellowship in Mohs micrographic and laser surgery at Harbor-UCLA and UCLA medical centers. Dr. Lee's research interests include Mohs micrographic surgery, laser surgery, and reconstructive surgery. He has authored numerous articles in prominent journals and serves as an associate editor of the Journal of Cosmetic Laser Therapy. Dr. Lee sees patients at his offices in Irvine and Costa Mesa, providing exceptional dermatological care.Generated from the website

Dr. J. Stuart Nelson is a UCI Health surgeon who specializes in port-wine stains, hemangiomas and other vascular malformations. Medical director of the Beckman Laser Institute & Medical Clinic, he has more than two decades of experience in the diagnosis, clinical management and treatment of these vascular malformations in infants, children and adults. Nelson earned his medical degree at the University of Southern California, followed by an internship and residency in general surgery at the UCI School Medicine. He also earned a PhD in biological sciences, with an emphasis on developmental and cell biology, from UC Irvine. Nelson, a distinguished professor in the Department of Surgery, developed the "Dynamic Cooling Device," which, in conjunction with pulsed dye laser technology, has become the standard of care to treat port-wine stain birthmarks, hemangiomas, other vascular malformations and a number of previously untreatable cutaneous diseases. The cooling technique also has been incorporated into laser surgical treatments for hypertrichosis, rosacea and scarring from acne, traumatic injury and surgical procedures. It has also been adapted for photorejuvenation procedures. His research combines his expertise in engineering, optics, medicine and surgery. He has published more than 360 scientific articles and 16 book chapters and is a past president of the American Society for Laser Medicine and Surgery (ASLMS). An internationally recognized expert in port-wine stains, hemangiomas and other vascular malformations, he is a frequent speaker at conferences around the world. Nelson, who directs the Vascular Birthmarks & Malformations Diagnostic and Treatment Center.

Dr. Anand K. Ganesan is a board-certified UCI Health dermatologist who specializes in skin cancer and skin pigmentation disorders, including vitiligo, melasma and albinism. He earned his medical degree at the Medical College of Wisconsin in Milwaukee, where he also received a doctoral degree in microbiology and molecular genetics. He completed an internal medicine internship at St. Mary Medical Center in Long Beach, Calif., followed by a residency in dermatology at the University of Texas Southwestern Medical School in Dallas. A prolific physician-scientist, Ganesan's research is focused on understanding how melanocytes respond to environmental cues, such as ultraviolet radiation and inflammation, to maintain normal homeostasis and how that homeostasis is disrupted by diseases processes, including melanoma and vitiligo. His work spans the spectrum from basic laboratory studies to clinical trials as he seeks to develop novel approaches to diagnosing and treating disease. He is the author or co-author of dozens of peer-reviewed publications that have appeared in prestigious medical journals, including the recent discovery of a new class of drugs with the potential to treat melanoma and other cancers.